latest news

News

The Strategy Behind EyeGate’s Acquisition of Panoptes

Heather Johnson / January 18, 2021
News

Lessons learned for Conducting Clinical Trials in Challenging Times

News

Looking Ahead to 2021, Finding Value in 2020’s Lessons

News

Novartis Steps Up Digital Strategy for AMD Treatments and Patient Support

News

800-pound Gorilla Doesn’t Deter Investors in Ophthalmology Sector

Pharmaceuticals & Genetics

Manufacturing Strategy Key to AGTC’s Next Steps for Gene Therapy Programs

August 18, 2020

Osmotica Will Commercialize and Supply Non-Surgical Droopy Lid Treatment via a Wholly Owned Subsidiary

August 5, 2020
AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

AbbVie Regroups after FDA Issues Complete Response Letter Rejecting Abicipar Pegol

July 9, 2020
With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

With Positive Phase III Results, Oyster Point Pharma Banks $120 Million from Public Offering

July 1, 2020
With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

With Fresh Funding, Eyenovia Pursues Platform for Focused Drug Delivery

April 29, 2020
Adverum, Gene Therapy, and AMD

Adverum, Gene Therapy, and AMD

March 25, 2020

devices & diagnostics

Emerging Glaucoma Devices See Beyond IOP

Emerging Glaucoma Devices See Beyond IOP

May 27, 2020
Soft CL slows myopia in children

Soft CL slows myopia in children

January 22, 2020
Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

Innovation Case Study: LensGen Focusing on a Complete Presbyopia Correcting IOL for Declining Vision

September 18, 2019
Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

Why Link Between Cognition and Vision May Emerge as a Focus of Innovation

August 28, 2019
How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

How Omega Ophthalmics Hopes to Redefine Use of the Capsular Bag with the Gemini Refractive Capsule

August 20, 2019

SUBSCRIBE TO OUR NEWSLETTER

Get The Latest News In Ophthalmic Innovation To Your Inbox.
!
!
!
SUBSCRIBE

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

Subscribe To OIS News

Get Our Weekly Newsletter About The Latest In Ophthalmic Innovation.
!
!
!
Subscribe

We respect your privacy and will never send you spam.

Something went wrong. Please check your entries and try again.

stay connected

next ois event

about ois

The OIS programs are presented annually by Healthegy, Inc.

Learn more about our world-class conferences.

Listen To The Podcast

OIS PODCAST 264 - [ Bill Link ] - Thumbnail

Powerhouse Investor Panel Shares Lessons for Building Out Your 2021 Portfolio

January 20, 2021
OIS Podcast
OIS PODCAST 263 - [ Michael_Nissen - James_Murray ] - Thumbnail

Venturing into Ophthalmology with ExSight

January 12, 2021
OIS Podcast
OIS PODCAST 262 - [ Jeff_Evanson - Terry Dagnon ] - Thumbnail

The Outlook on Getting Regulatory-Approved Bevacizumab to Market

January 5, 2021
OIS Podcast
OIS PODCAST 261 - [ Jerry St. Peter ] - Thumbnail

A Vision for Building a Business with Jerry St. Peter of Eyevance

December 22, 2020
OIS Podcast
Industry_Panel_Discussion - Pod 260 - Thumbnail

Retina Industry Leaders Impart Pearls of Wisdom for Finding Your Place in the Retina Space

December 16, 2020
OIS Podcast
OIS PODCAST 259 - [ Investing in the Future of Ophthalmology ] - Thumbnail

Investing in the Future of Ophthalmology

December 8, 2020
OIS Podcast

Deals

OIS Index Q2

OIS Index Rallies Back from COVID-Driven Decline

July 9, 2020
With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

With Amblyotech Buy, Novartis Makes a Transformation to the Ophthalmic Device Arena

June 10, 2020
AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

AbbVie’s Big Bet to Diversify with Allergan Pays Off So Far

May 20, 2020
Covid-19 Impact on Healthcare Company Valuations & Financings

Covid-19 Impact on Healthcare Company Valuations & Financings

April 22, 2020
OIS Index: No Immunity to Coronavirus Selloff

OIS Index: No Immunity to Coronavirus Selloff

April 8, 2020

watch videos from ois tv

OIS Index

OIS Index Rallies Back from COVID-Driven Decline

OIS Index Posts a Strong Finish to 2019

OIS Index Outperforms

OIS Index on Positive Upswing

OIS Index Deep in Bear Territory in Q3

OIS Index Posts Modest Gain for Q2; Ophthalmic Market Leader Alcon Joins Index

OIS Index Delivers Stellar First-Quarter 2019 Performance

ois press

@oistweets

most popular episodes

OIS 1 Year Podcast Anniversary

Year 1: What OIS Podcasts Were Most Popular? Part Two

OIS 1 Year Podcast Anniversary

Year 1: What OIS Podcasts Were Most Popular? Part One

OIS Podcast - Xiidra Prior to Shire: How SARcode Beat the Odds to Create a New Treatment for Dry Eye - Healthegy

Xiidra Prior to Shire: How SARcode Took on the Odds to Pursue a New Treatment for Dry Eye

OIS Podcast | Episode 198

With Positive Phase II Dry Eye Data in Hand, What’s Next for Aldeyra’s Promising Pipeline?